[HTML][HTML] Biomarkers in cancer detection, diagnosis, and prognosis

S Das, MK Dey, R Devireddy, MR Gartia - Sensors, 2023 - mdpi.com
Biomarkers are vital in healthcare as they provide valuable insights into disease diagnosis,
prognosis, treatment response, and personalized medicine. They serve as objective …

[HTML][HTML] The Evolving Paradigm of Antibody–Drug Conjugates Targeting the ErbB/HER Family of Receptor Tyrosine Kinases

P High, C Guernsey, S Subramanian, J Jacob… - Pharmaceutics, 2024 - mdpi.com
Current therapies targeting the human epidermal growth factor receptor (HER) family,
including monoclonal antibodies (mAbs) and tyrosine kinase inhibitors (TKIs), are limited by …

[HTML][HTML] Prospective Molecular Targets for Natural Killer Cell Immunotherapy against Glioblastoma Multiforme

LC Cooksey, DC Friesen, ED Mangan, PA Mathew - Cells, 2024 - pmc.ncbi.nlm.nih.gov
Glioblastoma multiforme (GBM) is the most common type of primary malignant brain tumor
and has a dismal overall survival rate. To date, no GBM therapy has yielded successful …

The Icarian flight of antibody-drug conjugates: target selection amidst complexity and tackling adverse impacts

H Liu, H Zeng, X Qin, W Ning, L Xu, S Yang, X Liu… - Protein & …, 2025 - academic.oup.com
Antibody-drug conjugates (ADCs) represent a promising class of targeted cancer
therapeutics that combine the specificity of monoclonal antibodies with the potency of …

Deguelin Restores Paclitaxel Sensitivity in Paclitaxel-Resistant Ovarian Cancer Cells via Inhibition of the EGFR Signaling Pathway

S Bae, S Bae, HS Kim, YJ Lim, G Kim… - Cancer Management …, 2024 - Taylor & Francis
Background Ovarian cancer is one of women's malignancies with the highest mortality
among gynecological cancers. Paclitaxel is used in first-line ovarian cancer chemotherapy …

[HTML][HTML] Prognostic and Predictive Roles of HER2 Status in Non-Breast and Non-Gastroesophageal Carcinomas

E Quaquarini, F Grillo, L Gervaso, G Arpa, N Fazio… - Cancers, 2024 - mdpi.com
Simple Summary Over the past years, the introduction of various anti-HER2 therapies has
significantly improved the outcome for patients with HER2-positive breast and …

[HTML][HTML] Structural Basis of Activity of HER2-Targeting Construct Composed of DARPin G3 and Albumin-Binding Domains

AG Konshina, EV Bocharov… - International …, 2024 - pmc.ncbi.nlm.nih.gov
Non-immunoglobulin-based scaffold proteins (SPs) represent one of the key therapeutic
target-specific and high-affinity binders in modern medicine. Among their cellular targets are …

[PDF][PDF] Men's gallbladder cancer: epidemiology, prevention, and treatment strategies

Y Pyo, KH Kwon - Journal of Men's Health, 2024 - oss.jomh.org
Herein, it was aimed to review the epidemiology, prevention, and treatment strategies for
men's gallbladder cancer (GBC).“Gallbladder cancer” and “GBC” were searched in four …

Ферменти метаболізму естрогенів та прогестеронів їх рецептори при раку молочної залози

МІ Пилипчак - 2024 - dspace.zsmu.edu.ua
Мета і задачі: дослідження особливостей клінічного перебігу РМЗ, експресії ER i PR,
акивність ароматази (АА), стероїд сульфатази (STS) і 17-бета гідроксистероїд …

[PDF][PDF] Obtención de los dominios extracelulares del HER1 y el HER2 acoplados a etiqueta de histidina para su empleo como antígenos de una vacuna específica por …

DCBS Ramírez - 2024 - fototeca.uh.cu
La estrecha relación existente entre los receptores para el factor de crecimiento epidérmico
humanos HER1 y HER2 (del inglés,“human epidermal growth factor receptors 1-2”) y la …